Spots Global Cancer Trial Database for adverse effects
Every month we try and update this database with for adverse effects cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma | NCT03930498 | Recurrent Nasop... | PD-1 blocking a... Chemotherapy IMRT | 18 Years - 65 Years | Sun Yat-sen University | |
| A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia | NCT01272440 | Acute Lymphobla... | 1 Year - 18 Years | Aarhus University Hospital | ||
| Skin Care for Cancer Patients: A Product Satisfaction Survey | NCT00871429 | Skin Toxicity | Lindi skin care... | 18 Years - | Northwestern University | |
| Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma | NCT01824615 | Ovarian Cancer Adverse Effects | Sunitinib | 20 Years - 80 Years | Cathay General Hospital | |
| Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer | NCT03294122 | Prostate Cancer Head and Neck C... | External beam r... External beam r... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old | NCT03155217 | Metastatic Mela... | 18 Years - 110 Years | University Hospital, Montpellier | ||
| Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma | NCT01824615 | Ovarian Cancer Adverse Effects | Sunitinib | 20 Years - 80 Years | Cathay General Hospital | |
| Laser Therapy of Benign Thyroid Nodules | NCT00150150 | Benign Solitary... Cystic Thyroid ... | Interstitial la... | 20 Years - 70 Years | Odense University Hospital | |
| Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer | NCT03294122 | Prostate Cancer Head and Neck C... | External beam r... External beam r... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma | NCT03930498 | Recurrent Nasop... | PD-1 blocking a... Chemotherapy IMRT | 18 Years - 65 Years | Sun Yat-sen University | |
| Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients | NCT01157052 | Neoplasms, Colo... Colorectal Canc... Colorectal Carc... | (supplement) Ca... | 18 Years - | AHS Cancer Control Alberta | |
| Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation | NCT03969693 | Mediastinal Lym... Hodgkin Lymphom... Non Hodgkin Lym... | Standard treatm... | 15 Years - 80 Years | Chang Gung Memorial Hospital | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance | NCT02171078 | Breast Neoplasm... | - | University of Wisconsin, Madison | ||
| Image-Guided Tumorboost of Bladder Cancer | NCT00963404 | Bladder Neoplas... | Radiation boost | 18 Years - | University of Aarhus | |
| Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer | NCT03294122 | Prostate Cancer Head and Neck C... | External beam r... External beam r... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation | NCT03969693 | Mediastinal Lym... Hodgkin Lymphom... Non Hodgkin Lym... | Standard treatm... | 15 Years - 80 Years | Chang Gung Memorial Hospital | |
| Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea | NCT00197873 | Colorectal Canc... | Lactobacillus R... Placebo adminis... | 18 Years - | University of Helsinki | |
| Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old | NCT03155217 | Metastatic Mela... | 18 Years - 110 Years | University Hospital, Montpellier | ||
| Image-Guided Tumorboost of Bladder Cancer | NCT00963404 | Bladder Neoplas... | Radiation boost | 18 Years - | University of Aarhus | |
| Feasibility Study: Conservative Treatment in Cervical Cancer | NCT02323841 | Stage IB1 Cervi... | conservative tr... | 18 Years - 40 Years | Catholic University of the Sacred Heart | |
| The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy | NCT03073031 | Adverse Effects | Tablet: Samsung... | 18 Years - | Odense University Hospital | |
| Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors | NCT00001301 | Lymphoma, Non-H... | - | National Institutes of Health Clinical Center (CC) | ||
| Skin Care for Cancer Patients: A Product Satisfaction Survey | NCT00871429 | Skin Toxicity | Lindi skin care... | 18 Years - | Northwestern University | |
| Skin Care for Cancer Patients: A Product Satisfaction Survey | NCT00871429 | Skin Toxicity | Lindi skin care... | 18 Years - | Northwestern University | |
| A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia | NCT01272440 | Acute Lymphobla... | 1 Year - 18 Years | Aarhus University Hospital | ||
| Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress | NCT01264562 | Breast Cancer | 18 Years - 65 Years | Ludwig-Maximilians - University of Munich | ||
| Image-Guided Tumorboost of Bladder Cancer | NCT00963404 | Bladder Neoplas... | Radiation boost | 18 Years - | University of Aarhus | |
| REBECCA - Research in Rehabilitation After Breast Cancer | NCT02056483 | Anxiety Depression Adverse Effects Health Behavior | Screening-based... | 18 Years - | Danish Cancer Society | |
| Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer | NCT01038154 | Esophageal Canc... Stomach Cancer | Pravastatin | 18 Years - | Hospital Donostia | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Laser Therapy of Benign Thyroid Nodules | NCT00150150 | Benign Solitary... Cystic Thyroid ... | Interstitial la... | 20 Years - 70 Years | Odense University Hospital | |
| Psychological distREsS hipEc oR pelVic Exenteration | NCT04956107 | Colo-rectal Can... | 18 Years - | University of Aarhus | ||
| Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer | NCT01248611 | Chronic Pain Cancer | fentanyl | 18 Years - | St. Olavs Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
